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Abstract: Donkey milk could be considered a good and safer alternative, compared to other types
of milk, for infants affected by cow’s milk protein allergy, when breastfeeding is not possible.
Interestingly, donkey milk has low allergenicity, mainly due to the low total casein amount, and the
content of some whey proteins that act as bioactive peptides. The amount of lysozyme, an antibacterial
agent, is 1.0 g/L, similar to human milk. Lactoferrin content is 0.08 g/L, with this protein being
involved in the regulation of iron homoeostasis, anti-microbial and anti-viral functions, and protection
against cancer development. Lactoperoxidase, another protein with antibacterial function, is present
in donkey milk, but in very low quantities (0.11 mg/L). β-lactoglobulin content in donkey milk is
3.75 g/L—this protein is able to bind and transport several hydrophobic molecules. Donkey milk’s
α-lactalbumin concentration is 1.8 g/L, very close to that of human milk. α-lactalbumin shows
antiviral, antitumor, and anti-stress properties. Therefore, donkey milk can be considered as a set of
nutraceuticals properties and a beverage suitable, not only for the growing infants, but for all ages,
especially for convalescents and for the elderly.
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1. Introduction
1.1. An Overview on Milk Composition
Milk is a natural beverage which meets the nutritional needs of infants, since it is one of the
most complete and highly nutritious foods. Nutritionally, milk is defined as “the most nearly perfect
food” due to its chemical composition. The principal constituents are water, lipids, carbohydrates,
and proteins (caseins and whey proteins). Furthermore, other minor constituents are present in milk,
such as vitamins, minerals, hormones, enzymes, and miscellaneous compounds. As well, there are
numerous immune components like growth factors, cytokines, nucleotides, antimicrobial compounds,
and specific immune cells. Thanks to these features, milk provides important nutritive elements,
immunological protection, and biologically active substances. The principal milk constituents vary
widely among species: lipids, less than 1–55%; proteins, 1–20%; lactose, 0–10%. Concentrations
of the minor constituents are also variable. Within any species, milk composition changes among
individual animals, between breeds, according to the stage of lactation, feed and health of the animal,
the environment, and the climatic situation, among many other factors [1].
The composition of milk reflects mainly the nutritional and physiological requirements of the
newborn, and even the profile of constituents therein changes markedly during lactation. The main
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changes are evident during the first days post-partum, especially regarding the immunoglobulin
fraction. The concentration of milk components remains relatively constant during mid-lactation and
changes noticeably in late lactation, due to the involution of the mammary gland tissue and the greater
influx of blood constituents [2].
Among the milk constituents, fats vary widely between different species both in their
concentration and chemical composition, from less than 1% in donkey milk, to more than 50% in
aquatic mammals [3]. Its composition depends on the energy requirements and on the nutritional,
genetic, and lactation characteristics of the species. Milk lipids are also important as a source of
essential fatty acids, such as linoleic and linolenic acid, and fat-soluble vitamins A, D, E, and K.
Considering this milk fraction, although 97–98% of lipids are triacylglycerols, small amounts of
di- and monoacylglycerols, free cholesterol and cholesterol esters, free fatty acids, and phospholipids
are also present. Phospholipids, which represent less than 1% of total lipid, are present mainly in the
milk fat globule membrane and other membranous material in the milk [4].
Regarding carbohydrate content in milk, lactose concentration varies from 0.7% to about 7.0%
among the different mammal species [4].
Lactose is synthesized in the epithelial mammary cells from two molecules of glucose: one
molecule of glucose is converted into UDP-galactose, which is condensed with a second molecule of
glucose by the complex of lactose synthetase. The latter is a dimer composed by the UDP-galactosyl
transferase and the whey protein α-lactalbumin (α-La), which is a regulatory subunit able to make
UDP-galactosyl transferase specific for glucose. Therefore, there is a positive correlation between the
concentrations of lactose and α-La in milk, (the milk of the Californian sea lion, which contains no
lactose, also lacks α-La). α-La probably has a regulatory role in the lactose synthesis, as well as in the
control of the osmotic pressure of milk [5].
Milk protein content ranges from 1% to 24% by milk weight depending on the mammalian species.
There are two major categories of milk proteins that are defined by their chemical composition and
physical properties: caseins and whey proteins. The caseins, which accounts for about the 80% of
milk proteins in ruminants, are responsible for the transport of calcium and phosphate, and for the
formation of a clot in the stomach for efficient digestion.
They are heat stable phosphoproteins synthesized in the mammary glands and found in the milk
of all mammals. Caseins are divided in α-caseins, which in turn comprise αs1-, αs2-, β-, and κ-caseins.
They differ in primary structure and type and degree of post-translational modifications. These proteins
are able to bind and transport relatively large amount of calcium, thanks to the presence of phosphates:
this makes caseins very important for the development of teeth and bones in newborns [6].
The casein proteins are nutritionally important also because of their high content in lysine, an
essential amino acid in humans: αs1- and αs2-casein have 14 and 24 lysine residues, respectively.
The whey proteins are those proteins which do not precipitate from solution when the pH of milk
is adjusted to 4.6. These proteins are referred to also as serum proteins or non-casein nitrogen, and are
a heterogeneous group of heat labile globular proteins constituted mainly by α-lactalbumin (α-La),
β-lactoglobulin (β-LG), serum albumin and immunoglobulins, and to a lesser extent by lactoferrin
and lysozyme. In the whey protein fraction, there are also enzymes, hormones, nutrient transporters,
growth factors, disease resistance factors, and others. However, contrary to caseins, they do not
contain phosphorus.
The ratio of casein/whey proteins is different among species—in human milk, the ratio is about
40/60, in mare’s milk it is around 50/50, while in cow, goat, sheep, and buffalo’s milk it is about 80/20.
These differences reflect the nutritional and physiological requirements of the newborn of these species [7].
The inorganic elements are defined as macroelements or microelements, depending on whether
they are present in the animal organism in smaller or greater quantities. The most important mineral
salts in milk are calcium, sodium, potassium, magnesium, phosphorus (inorganic), chlorides, and
citrates. Mineral elements are indispensable for the life of animals, as they participate in numerous
physiological functions.
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In milk, the inorganic elements are in solution or complexed into casein micelles.
In Tables 1 and 2 are reported respectively, the quantities of the main macroelements and
microelements in the milk of various species.
Table 1. Concentration of inorganic elements (mM) in the milk of different species (adapted from [8]).
Human Bovine Caprine Mare Swine Ovine
Calcium 7.8 29.4 23.1 16.5 104.1 56.8
Sodium 5.0 24.2 20.5 5.7 14.4 20.5
Potassium 16.5 34.7 46.6 11.9 31.4 31.7
Magnesium 1.1 5.1 5.0 1.6 9.6 9.0
Phosphorus 2.5 20.9 15.6 6.7 51.2 39.7
Chloride 6.2 30.2 34.2 6.6 28.7 17.0
Table 2. Concentration of some trace elements (µM) in mare, bovine, and human milk (adapted from [9]).
Bovine Mare Human
Zinc 3960 1835 2150
Iron 194 224 260
Copper 52 155 314
Manganese 21 14 7
Barium 188 76 149
Aluminium 98 123 125
Vitamins are important bioregulators and are classified as fat-soluble and water-soluble.
They are essential compounds for nutrition as they are involved in several functions: some are
hormone precursors (i.e., vitamin D), others act as antioxidants by sequestering free radicals (i.e.,
vitamins C and E), and others constitute the prosthetic group of enzymes (i.e., vitamin B complex).
Vitamin nutritional requirement varies from a few mg, to a few µg per day, depending on the considered
vitamin. In milk, vitamin content depends on the maternal vitamin status and, especially for the
water-soluble vitamins, from the maternal diet. In Table 3, the content of some fat-soluble and
water-soluble vitamins in the milk of various species is summarized.
Table 3. Vitamin content (mg/L) in the milk of different species (adapted from [10]).
Fat-Soluble Vitamins Bovine Caprine Mare Human Ovine
A and β-carotene 0.32–0.50 0.50 0.12 2.0 0.50
D3, Cholecalciferol 0.003 - 0.003 0.001 -
E, α-tocopherol 0.98–1.28 - 1.13 6.60 -
K 0.011 - 0.020 0.002 -
Water-soluble vitamins
B1, thiamine 0.37 0.49 0.30 0.15 0.48
B2, riboflavin 1.80 1.50 0.30 0.38 2.30
B3, niacin 0.90 3.20 1.40 1.70 4.50
B5, pantothenic acid 3.50 3.10 3.0 2.70 3.50
B6, pyridoxine 0.64 0.27 0.3 0.14 0.27
B7, biotin 0.035 0.039 - 0.006 0.09
B9, folic acid 0.18 n.d n.d 0.16 n.d
B12, cobalamin 0.004 0.70 0.003 0.5 0.007
C, ascorbic acid 21.0 9.0 17.2 43.0 4.25
1.2. Cow’s Milk Protein Allergy
It is well-known that the prevalence of adverse reactions to food is higher in children (6–8% in
the early years of life) than in adults (2.4%) [11]. Prospective studies, performed in various countries,
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showed that about 2.5% of children in the first year of life have allergic reactions to cow’s milk, which
is therefore considered the main cause of allergies in children [12].
Cow’s Milk Protein Allergy (CMPA) is clinically an abnormal immunological reaction to cow milk
proteins. It may be due to the interaction between one or more milk proteins and one or more immune
mechanisms, and resulting in IgE-mediated reactions. If the reactions do not involve the immune
system, they are defined as cow milk protein intolerance. IgE-mediated forms are often associated
with a higher risk of multiple food allergies and atopic conditions, such as asthma in later periods
of life. The causes of allergy to cow’s milk are manifold: first, the protein content of cow’s milk is
higher than that of human milk (3.6% versus 0.9%–1%); second, cow’s milk proteins are represented by
casein for the 80% and by the whey proteins for the 18% (in human milk, 40% caseins and 60% whey
proteins); third, β-lactoglobulin is absent in human milk, and for this reason, this protein is considered
as a potential allergen (allergen Bos d 5).
Cow’s milk caseins (αs1-, αs2-, β- and κ-casein) constitute the allergen Bos d 8, however, there is a
greater sensitiveness to the α-caseins (100%) and the κ-casein (91.7%). Among whey proteins, β-LG is
the most abundant whey protein in cow’s milk and it affects allergic patients in a percentage from 13%
to 76%. Also, bovine immunoglobulins (allergen Bos d 7), and in particular γ-globulin, are responsible
for CMPA clinical symptoms [13]. However, the allergic reaction to cow’s milk proteins occurs
when these proteins are poorly digested by the infant and hence their structure remains substantially
unchanged, since the polypeptide chain is not fractionated into amino acids because of insufficient
protease enzymatic attack, or a lack of a specific intestine enzyme. Therefore, the undigested protein
behaves as an antigen. This is not enough to determine allergic reactions, since the amount of absorbed
antigen is limited by anatomical barriers (mucus, epithelium) and/or eliminated by immunological
barriers, by a combination on the epithelial surface of antigen with secretory immune globulin (IgA).
However, if the anatomic barriers are weakened, because of inflammatory or IgA deficiency, the
penetration of large amounts of antigens occurs and the awareness and allergy in atopic subjects could
increase. CMPA occurs with gastrointestinal disorders for 50–60% of cases, skin diseases for 50–70%,
respiratory affections for 20–30% respirators, and anaphylaxis for 5–9% of cases [14].
Although milk allergy is considered transient, there are still some children who do not outgrow
their allergy by the age of 10, but also by their adulthood [15]. These latter patients have more severe
reactions and a different immunological pattern than those with transient allergy [16].
Once CMPA has been established, the therapy, as in all food allergies, should consist of the
absolute exclusion of milk or allergenic proteins of the cow’s milk (formulated milk and derivatives),
whereas in the case of breastfed children, on the complete elimination of milk protein from the mother’s
diet [17].
When breast milk is insufficient or unavailable, it is indispensable to choose an alternative milk
formula. In the case of infants affected by CMPA, the elimination of allergen administration usually
leads to the disappearance of the symptoms. However, some patients may also show the allergic
reaction if a substitute for cow’s milk is used, thus indicating multiple food allergies [18].
Multiple food allergies are difficult to treat—elimination from the diet of some nutrients, if not
properly balanced by the assumption of alternative nutrients, can lead to malnutrition and therefore
can stop growing [18].
2. Donkey Milk and Its Hypoallergenic Properties
Donkey milk was greatly appreciated for its benefits and versatility as a food for newborns since
ancient times, but only recently, scientific research has proven its importance in human nutrition.
This is especially for some categories of the population as the elderly and the infants affected by CMPA.
2.1. Historia Docet
In ancient Egypt, as evidenced by the images of bas-reliefs and painting from that time, donkeys
were very important for their use in agriculture and for daily works (Figure 1).
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the  Elder  described  its  virtues  regarding  skin wellness:  “It  is  believed  that  the  donkey’s milk 
eliminates skin wrinkles and makes the face softer and whiter. Some women are known to care for 
their face seven times a day, paying close attention to this number.” For this purpose, it is well‐known 
that Cleopatra and Poppaea used to immerse themselves in donkey milk to preserve their youth. In 
particular, Poppaea, the wife of Nero, used donkey milk every day for the bath and for this reason, 
she carried back 500 donkeys every time she left for a trip. It is said that Messalina also loved these 
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Europe, it is possible to find testimonies and documents describing the properties of donkey milk, 
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In those years, therefore, there was consciousness raising about the validity of donkey milk as a 
substitute for human milk, using it in nursing infants whenever the case requires it. This practice has 
been  in use until the 1950s. In fact, during these years, it was normal to use donkey milk  in cases 
where there was a shortage of breast milk, or when intolerance towards cow’s milk was observed. 
Figure 1. A bas-relief and a panting from ancient Egypt showing the use of donkeys for daily works.
The ancient Greeks considered donkey milk an excellent drug. In the 5th century BC, Herodotus
estimated it as a nutritious beverage, whereas Hippocrates recommended it as a medicine capable of
resolving several afflictions. Ancient Romans consumed donkey milk as a delicious drink and Pliny
the Elder described its virtues regarding skin wellness: “It is believed that the donkey’s milk eliminates
skin wrinkles and makes the face softer and whiter. Some women are known to care for their face seven
times a day, paying close attention to this number.” For this purpose, it is well-known that Cleopatra
and Poppaea used to immerse themselves in donkey milk to preserve their youth. In particular,
Poppaea, the wife of Nero, used donkey milk every day for the bath and for this reason, she carried
back 500 donkeys every time she left for a trip. It is said that Messalina also loved these “baths of
beauty” for the anti-wrinkle action that she guaranteed on the skin [19]. In Asia, Africa, and Europe,
it is possible to find testimonies and documents describing the properties of donkey milk, decanted
for its therapeutic, cosmetic, and food virtues. In Russia and Mongolia, the consumption of milk and
donkey milk, thanks to the abundant presence of vitamins A, B, and particularly C, compensated for
the low consumption of fruit, vegetables, and legumes. Nomads also used to have several donkeys
and horses for their milk. Leo Tolstoy affirmed: “Mare’s milk give vigor to my body and wings to
my spirit”. During the Renaissance, there was the first scientific consideration of this product, when
Francis I of France, based on the suggestion of his doctors, successfully used donkey milk against
stress and physical fatigue. In the nineteenth century, again in France, Dr. Parrot of the “Hôpital des
Enfants Assistés”, breastfed orphaned babies directly to the nipple of the donkey (Figure 2); moreover,
in several European cities, it was possible to meet some merchants who sold donkey milk.
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In those years, therefore, there was consciousness raising about the validity of donkey milk as
a substitute for human milk, using it in nursing infants whenever the case requires it. This practice
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has been in use until the 1950s. In fact, during these years, it was normal to use donkey milk in cases
where there was a shortage of breast milk, or when intolerance towards cow’s milk was observed.
Thus, nowadays, it important to take into account the many testimonies in the past on the
beneficial effects of donkey milk, but it is also important to give the right scientific approach that attests
and supports its innumerable properties that are here summarized: strengthens the immune system,
acts as a prebiotic on the gut flora, calms laryngeal irritation and cough, fights anaemia, fights skin
problems such as psoriasis, acne, and eczema, acts on skin disorders caused by stress, and is highly
digestible by newborns [20]. For these reasons, interest in donkey milk has recently begun, pressing
medical research to expand its literature on this topic. On the other hand, the scientific community
inherits a knowledge from the historical tradition of its great value—in particular, the importance
of donkey milk as the most suitable for infant feeding as it is the closest to human milk, its high
nutritional qualities, and high digestibility.
2.2. Donkey Milk and Its Affinity with Human Milk
It is well-known that among mammals, every species produces a kind of milk that is specific to
their newborns, ensuring them the optimal nutrition. This is also true for humans. The best milk for
an infant is breast milk, which responds perfectly to the needs of healthy growth and harmonious
development. However, when it is not possible to breastfeed, and especially in the case of CMPA, it is
necessary to find a safe and valid alternative milk that meets the needs of the infant. The various kinds
of alternative milk are certainly valid and ensure good child growth, however, sometimes they are
characterized by an unpleasant taste and a high cost. Further, in the case of multiple food allergies,
may themselves cause unwanted allergic reactions. Donkey milk is considered a milk similar to human
milk, especially regarding its protein composition. Therefore, as well as breast milk, it is able to
respond to all the food needs of the newborn. Donkey milk is also an important food in the geriatric
field and in cases of calcium deficiency [21].
Some studies have shown that donkey milk, which has the organoleptic characteristics closer
to breast milk, may be the treatment of choice in children with food allergies in early life, who often
do not respond to other therapies. Unlike other breast milk substitutes, characterized by nutritional
deficiencies and induction of allergic reactions, this natural food proves to be able to nourish infants
at low risk of allergenicity and also allows for the development of a normal and complete immune
system [22]. With this in mind, we can consider donkey milk not simply as a food, but as a nutraceutical.
We consider it to be used not only in early childhood nutrition, but also as a supplement in the diet of
adults and the elderly.
In Table 4, the average percentage composition (g/100 g) of donkey milk (evidenced in bold) is
shown, compared to that of human, bovine, mare, ovine, and caprine milk [23,24]. The fat content in
donkey milk is very close to that of mare milk, but low when compared to that of other species,
including human milk. As a consequence, the average energy value found in donkey milk is
1939.4 kJ/kg, similar to that of mare’s milk, but lower with respect to the milk of other species [25].
This low energy value could be a problem for the infant’s energy intake if the diet of the latter is
based only on donkey milk. However, this problem could be overcome through a supplement of
medium-chain triglycerides or sunflower oil in the milk [26,27]. Regarding the lipid composition,
donkey milk contains a lower amount of saturated fatty acid (SFA) and higher level of essential fatty
acid (EFA) than that of bovine milk, and a high polyunsaturated fatty acids (PUFA) content (especially
α-linolenic acid and linoleic acid). Furthermore, this milk is characterized by a low ratio of n-6 to n-3
fatty acids [28,29].
The total donkey milk dry matter is 9.61%, ashes corresponding approximately to 0.43%.
The proportion of non-protein nitrogen is very close to that found in human milk. The biological
significance of the non-protein fraction is not well clarified. However, this fraction includes urea, uric
acid, creatinine, nucleic acids, amino acids, and nucleotides, which seem to be very important for
neonatal development [30].
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Table 4. Percentage composition (g/100 g) of donkey milk (evidenced in bold) and comparison with
other species.
Milk Water Dry Matter Fat Proteins Lactose Ashes Energy Value (kJ/kg)
Human 87.57 12.43 3.38 1.64 6.69 0.22 2855.6
Donkey 90.39 9.61 1.21 1.74 6.23 0.43 1939.4
Mare 90.48 9.52 0.85 2.06 6.26 0.35 1877.8
Bovine 87.62 12.38 3.46 3.43 4.71 0.78 2983.0
Caprine 86.77 13.23 4.62 3.41 4.47 0.73 3399.5
Ovine 80.48 19.52 7.54 6.17 4.89 0.92 5289.4
Adapted from [23,24].
Donkey milk contains a high level of lactose, which is involved in bone mineralization. Its lactose
concentration, in particular, is close to that of human milk [22]. It is also responsible for the sweet
taste of donkey milk, which is much more pleasing to the palate of the newborn with respect to the
other breast milk substitutes. Lactose stimulates the intestinal absorption of calcium in the infant
because in these subjects, the enzyme β-galactosidase (which hydrolyses lactose into galactose and
glucose) is highly expressed. Some studies in fact demonstrated that β-galactosidase-deficient subjects
absorbed less calcium than β-galactosidase-normal subjects because are the hydrolytic products of
β-galactosidase (glucose and galactose) that promote the calcium absorption [31,32]. Therefore, even
after weaning, if a balanced diet is followed, donkey milk favors bones mineralization.
Finally, the presence of lactose makes donkey milk a suitable substrate for the preparation of
fermented beverages [33].
Considering donkey milk protein content, the average of total caseins and whey proteins contents
were found similar to those of human milk, but lower when compared to bovine milk (Table 5).
The content of casein was found to be slightly higher in donkey milk than in human milk, but
significantly lower than that of sheep and bovine milk (Table 5). Moreover, the ratio casein/whey
proteins were higher in donkey milk than human milk, but were closer to that of breast milk substitution
products. In contrast, in ruminant milk, this ratio is four times higher than that of donkey milk and
seven times greater than that of humans [34].
From the evaluation of the sequence homologies of αs1-casein and β-casein from donkey,
human, and cow, the highest homology was found between the donkey and human species both for
α1-casein (42% donkey/human versus 31% cow/human) than for β-CN (57% donkey/human vs.
54% cow/human) [35]. This data, strictly dependent on the amino acid sequence of the comparative
proteins, together with the low quantitative level of these two fractions in the donkey milk, justifies
and demonstrates the best tolerability of the milk of this species.
In order to find out more information about the nutritional properties and the hypoallergenic
value of donkey milk, several studies have been conducted in recent years in order to examine the
protein component of this nutritionally important beverage.
3. Bioactive Proteins and Peptides in Donkey Milk
In Table 5 are listed in detail the different protein fractions (caseins and whey proteins) identified
in donkey milk, together with the respective amount (g/L). Donkey’s milk presents an amount of α-La
rather close to that determined in human milk a high amount of β-LG, which is completely absent in
human milk. This whey protein has been indicated, as mentioned, as the major allergen of cow’s milk,
together with caseins.
This data could affect the hypoallergenic potential of donkey milk, although the cases where this
milk has been used in the treatment of CMPA have proved its efficacy with very high percentages
of resolution of the allergic problem. The hypothesis formulated by several pediatricians is that
caseins are the main responsible of CMPA, while β-LG plays a much smaller role in the occurrence of
this pathology.
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Table 5. Main proteins content in donkey milk (evidenced in bold) and comparison with bovine,
caprine, and human milk.
a Bovine (g/L) b Donkey (g/L) c Caprine (g/L) a Human (g/L)
Total protein content 32.0 13–28 28–32 9–15
Total caseins 27.2 6.6 25.0 5.6
Total whey proteins 4.5 7.5 6.0 8.0
αs1-casein 10.0 n.d. 10.0 0.8
αs2-casein 3.7 n.d. 3.0 -
β-casein 10.0 n.d. 11.0 4.0
κ-casein 3.5 trace 4.0 1.0
α-lactalbumin 1.2 1.80 6.0 1.9–2.6
β-lactoglobulin 3.3 3.7 1.2 -
Lysozyme trace 1.0 trace 0.04–0.2
Lactoferrin 0.1 0.08 0.02–0.2 1.7–2.0
Immunoglobulins 1.0 n.d. 1.0 1.1
Albumin 0.4 n.d. 0.5 0.4
a [36]; b [37,38]; c [39].
Of note is the lysozyme content in the donkey milk, in a quantity significantly greater than that
one determined in human milk; this peptide has a bactericidal action, since it breaks the bacterial cell
wall. It is also believed that the high presence of this compound gives the donkey milk the peculiarity
of preserving its organoleptic and especially microbiological characteristics for a long time unchanged.
Donkey milk whey proteins content was also checked during the lactation period [37] (Table 6).
Lysozyme amount decreased linearly during lactation—this protein is a natural antimicrobial agent;
therefore, its amount tends to be higher after parturition with respect to the end of lactation. This is
in order to ensure to the newborn an adequate protection against bacterial agent, since in the first
days of life, the immune system of the child is not mature. α-La content doubles up to the nineteenth
day of lactation then stabilizes—this behavior reflects the important role of this protein in the lactose
synthesis. Finally, the content of β-LG remains stable during lactation.
Table 6. Content (g/L) of lysozyme, β-LG and α-La in donkey milk collected in different stages
of lactation.
Lactation Period β-LG α-La Lysozyme
60 n.d. 0.81 1.34
90 4.13 1.97 0.94
120 3.60 1.87 1.03
160 3.69 1.74 0.82
190 3.60 1.63 0.76
Adapted from [37].
In the following paragraphs will be discussed in more detail the protein/peptide components of
donkey milk, their potential nutraceutical function, and their impact on human health.
3.1. Casein Fraction
Donkey milk casein fraction is represented mainly by αs1- and β-caseins, which showed
a great variability due to the degree of phosphorylation and the presence of genetic variants.
The composition of donkey milk caseins has been the subject of several studies performed by
one-dimensional electrophoresis, two-dimensional electrophoresis, structural MS analysis, and
reversed phase-HPLC [38,40,41]. The presence of αs2-casein and k-casein was also found in donkey
milk even if at small amounts [40,41]. By two-dimensional electrophoresis were found more than
14 protein spots, which were in turn found corresponding mainly to αs1-casein and β-casein, as also
evidenced by reversed phase-HPLC [37,38]. Donkey milk β-caseins showed a pI ranging from 4.63 to
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4.95 and a Mr varying from 33.74 to 31.15 kDa. This heterogeneity is due to the presence of two genetic
variants of β-casein: a full length one characterized by the presence of 7, 6, 5 phosphate groups and pI
range of 4.74–4.91 and a spliced variant (-923 amino acids) carrying 7, 6, 5 phosphate groups and a
pI range of 4.72–4.61. By two-dimensional electrophoresis experiments were found five αs1-casein in
donkey milk: three of them showed similar molecular weight (about 31.15 kDa) but different pIs (range
5.15–5.36), the other two showed a lower molecular weight (27–28 kDa) and pI of 5.08 and 4.92 [38].
Also in the case of αs1-casein the heterogeneity is due to the presence of 5, 6 and 7 phosphate groups
and non-allelic spliced forms [41]. These latter authors found in donkey milk the presence of at least
four αs1-casein main components, six β-casein components, three αs2-casein components (containing
10, 11, and 12 phosphate groups), and eleven κ-caseins (evidenced after specific immunostaining).
In the case of κ-casein, this high heterogeneity is probably due to a different glycosylation pattern [41].
In Table 7 are summarized the casein component until found in donkey milk.
Table 7. Donkey milk casein components. The data reported in this table were obtained from: [38,40,41].
Casein Mr (kDa) pI
β-casein (full-length) 33.74 4.63
β-casein (full-length) 33.54 4.72
β-casein (full-length) 33.10 4.82
β-casein (full-length) 33.54 4.92
β-casein (spliced) 31.66 4.68
β-casein (spliced) 31.48 4.80
β-casein (spliced) 32.15 4.88
β-casein (spliced) 31.15 4.95
αs1-casein (full-length) 31.20 5.15
αs1-casein (full-length) 31.14 5.23
αs1-casein (full-length) 31.14 5.36
αs1-casein (spliced) 28.26 5.08
αs1-casein (spliced) 27.24 4.92
αs2-casein 26.83 n.d.
αs2-casein 26.91 n.d.
αs2-casein 26.99 n.d.
Eleven κ-caseins n.d. n.d.
3.2. Whey Protein Fraction and Its Impact on Human Health
Whey protein fraction has been well characterized in donkey milk by several authors.
Some proteins possess important nutraceutical properties and may be beneficial for human health.
Hereafter, the main milk whey proteins are described separately and in detail.
3.2.1. β-Lactoglobulin
β-lactoglobulin (β-LG) is the most represented whey protein in ruminants and is also present
in milk of some but not all species. It is not found in the milk of rodent, human, and lagomorph.
In donkey milk β-LG content is 3.75 g/L, a value very close to that found in bovine milk (3.3 g/L) and
mare milk. A proteomic study was performed by two-dimensional electrophoresis, evidenced in at
least three main isoforms of donkey milk β-LG which differ in relative molecular mass (Mr) and pI
value (Mr/pI: 21.9/4.46; 20.0/4.40; 20.58/4.12) [38] (Figure 3).
Other authors revealed that in donkey milk β-LG exists in two isoforms: β-lactoglobulin I
(β-LGI the major form, 80%), and β-lactoglobulin II (β-LGII, present in minor amount) [42,43].
Other studies found the presence of one genetic variant of β-LGI (β-LGIB), two genetic variants
of β-LGII (namely β-LGIIB and β-LGIIC), and a third minor β-LGII variant (β-LGIID) [44,45]. β-LG is
a small protein with 162 amino acid residues (Mr ~18.4 kDa)—its sequence and its three-dimensional
structure (it is a dimer) show that it is part of the family of lipocalins which includes a large and
diversified group of over 50 extracellular proteins that originate from a large variety of tissues in
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animals, plants, and bacteria. A typical lipocalin consists of a peptide chain of 160–180 amino acids,
folded into 8 antiparallel filaments that produce a β-sheet arranged in a conical structure called
β-barrel, in which is located the hydrophobic pocket, able to bind different hydrophobic molecules.
In fact, members of this family are characterized by some common molecular properties: the ability to
bind several small hydrophobic molecules, the ability to bind to specific cell surface receptors, and
the ability to form complexes with soluble macromolecules. For these reasons, lipocalins can act as
specific transporters, for example, for serum retinol-binding protein (RBP) [46]. The high affinity of
β-lactoglobulin for a wide range of compounds and its high amount in milk has suggested several
functions for this protein. In addition to transporting hydrophobic molecules, this protein seems to be
involved in enzyme regulation, and in the neonatal acquisition of passive immunity [46].Beverages 2017, 3, 34    10 of 20 
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As regard to the hydrophobic ligands, they are mainly represented by long chain fatty acids,
retinol, and steroids. In milk, fatty acids, rather than retinol, represent endogenous ligands; the latter,
however, being more soluble in fat, is indirectly transferred from the mother to the newborn through
the β-LG. However, the effective role of this protein is not certain. This is due to two main reasons:
the first is given by the presence of other lipocalins that have a similar function, the second being a
simple reasoning based on the fact that if β-LG played an indispensable role, it would be expressed in
all mammalian species and not just in some. One hypothesis on the role of this protein may be that the
real β-LG function may be related to the physiology of the mother, rather than to that of the newborn.
An important issue has been the identification in cow and goat of a pseudo-gene (ancestral
genes that have lost their ability to be expressed), which appeared very similar to the equine β-LG-II
sequence [46]. An explanation of the presence of the pseudo-gene could be that the protein served for
its true function elsewhere then it may be expressed in the mammary gland of some species (but not
all) as source of nutrition.
Kontopidis and co-workers [46] examined the β-LG sequences of the various species together
with the other lipocalins, creating a genealogical tree from which they noted that RBPs are clearly
distinct from the lactoglobulins, with the exception of a single protein: the glycodelin. This is a protein
expressed in a large amount during human pregnancy (first three months) in the endometrium and
seems to be involved in immunosuppression and/or cellular differentiation.
Therefore, it could be possible to postulate that in many species this gene has undergone a
duplication event and now it is expressed during lactation for nutritional purposes. Likewise, in some
species, such as rodents, lagomorphs, and humans, the formation of a pseudogene has ceased, and
consequently ceased its presence in the milk of these species [46].
Recently it was shown by Liang and co-workers [47] that β-LG is able to interact with resveratrol,
a natural polyphenolic compound with antioxidant activity forming a 1:1 complex that enhances the
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photostability and hydrosolubility of resveratrol, improving its bioavailability. Furthermore, it has
been shown that β-LG is able to form complexes also with folic acid; therefore, it may be used as an
effective carrier of this important vitamin in food [48].
3.2.2. α-Lactalbumin
Donkey milk contains a considerable amount of α-La with a concentration of 1.80 g/L, very close
to the amount found in human and bovine milk [37]. Thanks to two-dimensional electrophoresis it
was possible to identify in donkey milk the presence of two isoforms of α-La that showed different
pI values: 4.76 and 5.26 [38]. The presence of two isoforms in donkey milk was already observed
by Cunsolo and co-workers [45], who found oxidized methionine (at position 90 of the amino acid
sequence) form for α-La, which presumably derive by in vivo oxidative stress.
α-La is a small protein (Mr 14.2 kDa), with a binding site with Ca2+ ion. It has been hypothesized
that α-La gene originated 300–400 million years ago from an ancestral lysozyme gene, by gene
duplication. This is the reason why α-lactalbumin shares 40% sequence identity with lysozyme (also
their three-dimensional structure looks very similar).
This protein consists of two domains: one large α-helical domain and another one smallest
constituted by β-sheet. These two domains are linked together by calcium binding loop. Further, they
are held together by a disulphide bridge between cysteine residue 73 and 91, which forms also the
calcium binding loop, and another disulphide bridge between 61 and 77 cysteine residues. Definitively,
the overall structure of α-La is stabilized by four disulphide bridges [49].
This protein is important for various reasons. First of all, α-La is part of the enzymatic
complex that regulates lactose synthesis in the breast gland and also facilitates the absorption of
lactose in the intestine. However, α-La has myriad of other functions, among all anti-inflammatory
and antinociceptive functions. Some authors showed that the proteolytic digest of α-La released
three peptides with bactericidal properties. In particular, two fragments were obtained from
the tryptic digestion and the third one was obtained by fragmentation of α-La by chymotrypsin.
These polypeptides were mainly active against Gram-positive bacteria, whereas they were less active
on Gram-negative bacteria. If α-La was digested by pepsin, the polypeptide fragments obtained did
not show any antibacterial activity. Since undigested α-La does not possess bactericidal activity, it
was suggested as a possible antimicrobial function of α-lactalbumin only after its partial digestion by
endopeptidases [50].
Other authors purified a α-La folding variant from human milk with bactericidal activity against
antibiotic-resistant strains of Streptococcus pneumoniae. In these experiments, the native α-La was
converted to the active bactericidal form by anion-exchange chromatography in the presence of a C18:1
fatty acid (oleic acid) [51]. However, this antibacterial activity was selective only for streptococci—in
fact, Gram-negative and other Gram-positive bacteria resulted resistant.
Finally, it was demonstrated that native α-La possesses several classes of fatty acid binding
site [52].
Some multimeric human α-La derivative induces an increase of Ca2+ level and acts as an
apoptosis-inducing agent [53,54]. In fact, it has been shown that multimeric α-La can bind to the cell
surface, enter in the cytoplasm and accumulate in the nuclei. Further, the direct interaction of α-La
with mitochondria lead to cytochrome c release, which, in turn, start the caspase cascade which is
involved in apoptosis [55].
In particular, it has been shown that in human milk the α-lactalbumin-oleic acid complex, called
HAMLET (Human α-lactalbumin Made Lethal to Tumor Cells), is capable of inducing selective
apoptosis towards cancer cells, but leaves fully differentiated cells unaffected. The in vivo effects of
HAMLET have been investigated in patients and in tumor cell lines, and the results indicated that
HAMLET limits the progression of human glioblastomas in a xenograft model and removes skin
papillomas in patients. In tumor cells, HAMLET enters the cytoplasm and then enters the nuclei
where it accumulates. Here, HAMLET binds to histones and disrupts chromatin organization [56].
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Furthermore, it has been shown that the acid pH in the stomach of the breast-fed child can promote
the formation of HAMLET, which contribute to the protective effect of breastfeeding against childhood
tumors [56].
HAMLET can be produced starting from a purified native α-lactalbumin which is initially partially
unfolded by ethylenediaminetetraacetic acid (EDTA), a chelating agent able to remove the calcium ion.
The protein adopts the apo-conformation that exposes a new fatty acid binding site, which has high
specificity for oleic acid.
Subsequently, the protein is subjected to an ion-exchange chromatography on a matrix conditioned
with oleic acid, which binds to α-La and stabilize the altered protein conformation. The complex eluted
from the column in presence of high salt solution is the HAMLET complex [56].
3.2.3. Lysozyme
In donkey milk, lysozyme has been purified and characterized by a reversed-phase HPLC,
followed by a 15% polyacrylamide gel electrophoresis under denaturing conditions (15% SDS-PAGE).
Two-dimensional electrophoresis revealed the presence of one spot corresponding to the lysozyme,
with a Mr of 14.5 kDa and a pI of 9.40 [37,38]. However, in the literature are reported the presence
of two isoforms of donkey milk lysozyme: lysozyme A (Mr 14.631 kDa) and lysozyme B (Mr
14.646 kDa), which differ for an oxidized methionine at position 79. This derives, most likely, from
a post-translational modification [44,45]. Donkey milk contains 1.0 g/L of lysozyme (higher with
respect to the lysozyme content of human milk), while in goat and bovine milk this protein is virtually
absent. Lysozyme belongs to the class of hydrolases, and specifically is a glycosidase. It has a structure
consisting of two domains: one domain is essentially composed of α-helices, and the other consists
of an anti-parallel β-sheet and two α-helices. The three-dimensional configuration of the molecule is
maintained by the presence of three disulphide bridges: two located in the alpha-helix domain, and
one in the β-sheet. In its inner part there are few polar residues.
Under the bioactive aspect, this enzyme exerts a bactericidal action, as it disrupts the cell wall of
the microorganisms; its hydrolytic reaction occurs only on the O-glycosyl compounds. This results in
the cleavage of the glycoside bond between the carbon 1 of the glucosamine and the carbon 4 of the
muramic acid, thereby causing the broken of bacterial cell wall.
Various experiments have shown that due to the high content of lysozyme in donkey milk, raw
milk of this species, different to raw cow milk, does not change its organoleptic and microbiological
characteristics over time. This suggests a long shelf life of donkey milk which could be stored longer
with respect to raw cow milk [57]. In another study on the antimicrobial properties of donkey milk,
Šaric´ and co-workers found a positive correlation between the high content of lysozyme and the
antibacterial activity against Listeria monocytogenes and Staphylococcus aureus [58].
Furthermore, thanks to its bactericidal action, lysozyme may help to prevent intestinal infections
in infants, thus facilitating a proper digestion and normal absorption of nutrients.
In addition, it has been shown that this enzyme has other physiological functions:
anti-inflammatory activity, immunoregulatory activity, and antitumor activity. In particular, studies
have shown that lysozyme inhibits angiogenesis and has antitumor activity. Recent in vitro studies
have noted an anti-proliferative and antitumor activity of donkey milk against the adenocarcinoma
human alveolar basal epithelial cells (A549) through the stimulation of IL-2, IFN-g, IL-6, TNF-a, and
IL-1b cytokines production, the modification of the cell cycle, and the induction of the apoptosis
process [59]. Furthermore, it has been shown that equine lysozyme, which, as discussed before, is
structurally homologous to α-lactalbumin, can form complexes with oleic acid called ELOA (equine
lysozyme and oleic acid). This, in analogy to the HAMLET complex, may show cytotoxic activity.
Recently, it has been shown that ELOA also displays bactericidal activity against pneumococci—in
particular these complex binds to Streptococcus pneumoniae, causing perturbations of the plasma
membrane, such as depolarization and rupture, and consequently calcium enters the cells. As discussed
before, the increase of intracellular calcium induces apoptosis. Furthermore, analogously to HAMLET,
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ELOA-induced apoptosis is accompanied by DNA fragmentation into high molecular weight
fragments [60]. Equine lysozyme also possesses the high-affinity calcium-binding site of α-lactalbumin,
whose amino acid sequence is highly conserved [56].
3.2.4. Lactoferrin
Lactoferrin, also called lactotransferrin, is an 80.0 kDa glycoprotein belonging to the transferrin
family, is an iron-chelating glycoprotein, and has a structure composed of two homologous domains,
each binding a ferric ion (Fe3+) and a carbonate anion. It is a protein that shows several functions,
including regulation of iron homoeostasis, cell growth and differentiation, defense against infectious
agents, anti-inflammatory and cancer protection, and ultimately a trophic activity on the intestinal
mucosa [61]. Lactoferrin is present mainly in milk, and also in small quantities in exocrine fluids such
as saliva, tears, bile, seminal fluid, and pancreatic juice. The plasma contains a low concentration of
lactoferrin, but during inflammatory reactions, the neutrophil granulocytes release this protein by
increasing the concentration of the plasma pool. Lactoferrin concentration is quite high in human milk
(1.0 mg/mL) compared with bovine milk (0.02–0.2 g/L), sheep (0.14 g/mL), and goat (0.02–0.40 g/L).
However, in all species, the highest lactoferrin concentration is found in the colostrum (in the human
colostrum is about 7.0 g/L) and may increase in the case of breast infection. In mare milk, lactoferrin
concentration is about 0.10 g/L, while in colostrum ranges from 1.5 to 5.0 g/L. In donkey milk was
found a lactoferrin concentration of 0.08 g/L, close to that of mare milk, cow, and goat, but lower than
the average concentration found in human milk [38]. Lactoferrin shows two different mechanisms of
antimicrobial activity. The first mechanism has a bacteriostatic effect, because, thanks to its high affinity
with iron, it can subtract this metal to iron-dependent bacteria, which are thus deprived of essential
nutritious growth. Thanks to its bacteriostatic properties, due to the ability to bind iron, lactoferrin
is capable of delaying growth to a wide variability of microorganisms, including a wide range of
gram-positive and gram-negative bacteria and some type of yeasts. However, the bacteriostatic
effect is often temporary because some gram-negative bacteria became able to adapt themselves to
the restrictive conditions of iron through the synthesis of low molecular weight chelating agents
(siderophores) that are able to remove iron from lactoferrin. The second antimicrobial activity is due to
a direct-action mechanism of lactoferrin that is capable of damaging the cell wall of gram-negative
bacteria, binding to lipopolysaccharide A, to the porins, and other surface molecules of the cell wall
of some microorganisms. Lactoferrin has an important anti-inflammatory role associated with the
microbial challenge. It has been shown through animal studies that the administration of lactoferrin
protects against gastritis acting against Helicobacter pylori [62]. This protective effect against infections
seems to be due to the fact that lactoferrin promotes the inhibition of several pro-inflammatory
cytokines such as tumor necrosis factor alpha (TNFa), interleukin-1β (IL-1β) and IL-6. Lactoferrin is
upregulated in several inflammatory disorders such as neurodegenerative disease, arthritis, allergic
skin, inflammatory bowel disease, and lung disorders [61]. Furthermore, lactoferrin, besides the many
biological roles already known, stimulates the proliferation and differentiation of osteoblasts as shown
by Cornish and co-workers [63].
From the digestion of lactoferrin derive some peptides with antimicrobial activity against
pathogens, namely LF1-11, lactoferrampin, and lactoferricin. All of these derive from the N-terminal
domain of lactoferrin and are conserved in lactoferrin of most species. The most important peptide is
lactoferricin which exerts its antibacterial activity against several bacteria, viruses, fungal pathogens,
and protozoa. Furthermore, this peptide displayed other activities, such as inhibition of tumor
metastasis in mice and induction of apoptosis in THP-1 human monocytic leukemic cells. [64].
Comparing the antimicrobial activities of lactoferricin from human, bovine, murine, and
caprine, it was shown that bovine lactoferricin was the most active. In fact, its minimal inhibitory
concentration (MIC) against some Escherichia coli strains was about 30µg/Ml, whereas in the
lactoferricin derived from human lactoferrin, IT was about 4 times higher. The higher antimicrobial
activity of bovine lactoferricin seems to be due to the presence of high amounts of net positive charges
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and hydrophobic residues [64]. Another group of peptides which derives from lactoferrin digestion
includes lactoferroxins. These are classified as opioid peptides, since they show effects similar to that
of opiates [65]. Opioid peptides can be also obtained from the digestion of caseins (casomorphines).
3.2.5. Lactoperoxidase
Lactoperoxidase (LPO) is an enzyme predominantly secreted by the mammal gland, but it can
be found also in other glandular secretions. This enzyme is part of the peroxidase family and is a
glycoprotein consisting of 608 amino acids with a molecular mass of 78.0 kDa. Its secondary structure
consists of α-helices and two short-anti-parallel β-sheets which form, together, a spheroidal structure
with a heme group in the center linked covalently. To the enzyme is also linked with a calcium ion,
important for the maintaining of the protein structural integrity [66]. The LPO system catalyzes the
oxidation of several substrates, by using hydrogen peroxide (H2O2) as shown in the following reaction:
Reduced substrate + H2O2 → Oxidized product + H2O
Reduced substrates include thiocyanate (SCN−) and iodide ions (I−), whereas hydrogen peroxide
can derive from the reaction of glucose with oxygen catalyzed by the enzyme glucose oxidase.
Once formed, the oxidized products have a potent bactericidal activity against bacteria, virus, parasite,
fungi, and mycoplasma [67]. LPO system has a bacteriostatic effect also on Listeria monocytogenes,
therefore, it should be used for controlling the development of this bacterium in the raw milk at
refrigeration temperatures. Furthermore, some authors co-administered lactoferrin and LPO to mice
infected with influenza virus in order to attenuate pneumonia [68]. Thanks to its bacteriostatic activity,
LPO is widely used in the preservation of food.
Donkey milk LPO enzymatic activity was 4.83± 0.35 mU/mL and its amount 0.11± 0.027 mg/L [38].
This value resulted 100 times lower with respect to the bovine milk LPO (0.03–0.1 g/L), but very similar to
that found in human milk (0.77± 0.38 mg/L) [67,69].
The three above-mentioned protective factors (lysozyme, LPO, and lactoferrin) may have additive
or synergic effects, as reported by some authors [70,71], and, as known, all of them contribute to the
protection of the newborn animal. It is interesting to notice that these antimicrobial factors are almost
the same in different species, but their amount and importance can vary widely. In fact, the content
of lysozyme in donkey and human milk is considerably higher than that of bovine milk, whereas
lactoperoxidase is present in small amounts in donkey and human milk, but is high in bovine milk
(Table 8).
Table 8. Amount of the three main antimicrobial factors in human, bovine, and donkey milk.
Milk Lysozyme (g/L) Lactoperoxidase (mg/L) Lactoferrin (g/L)
Human 0.12 0.77 0.3–4.2
Donkey 1.0 0.11 0.08
Bovine Trace 30–100 0.10
Adapted from [38].
Furthermore, it has been demonstrated that the immunoglobulins found in the milk exert
a synergistic effect on the activity of these non-specific antimicrobial factors, as demonstrated
by Tenuovo and co-workers [70] in the case of the LPO system, whose antimicrobial activity
against Streptococcus mutans increases considerably if the system is incubated with secretory
IgA. The antimicrobial activity enhancement seems to be due to a binding between LPO and
immunoglobulins (IgA). The result of this interaction is a stabilization of the enzymatic activity
of lactoperoxidase.
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3.2.6. β-Casein Fragments
Bioactive peptides derive from caseins and they possess multifunctional properties. In fact, they
initially act as physiological modulators of metabolism during intestinal digestion of food and when
absorbed, they can act on the various target organs of the organism. In particular, bioactive peptides
play several roles in the cardiovascular, digestive, nervous, and immune systems [72].
Cunsolo and co-workers [45] found the presence of β-casein fragments in the donkey milk whey
protein fraction, which can derive from the partial digestion of β-casein by endogenous proteases.
In particular, these authors found that the donkey’s β-casein fragment 199–226, with molecular mass
of 3043.0 Da, share 40% sequence homology with the human β-casein fragment 184–210, which shows
antimicrobial activity. Furthermore, the N-terminal sequence of the donkey β-casein fragment 199–226,
has homology with the bovine β-casein fragment 193–198, which has anti-hypertensive properties [73]
(Figure 4).
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However, the function and the impact on human health of the bioactive peptides derived from
donkey milk casein is not well elucidated yet. Therefore, for the time being, it is possible only to
speculate on the possible function of these peptides based on sequence similarities with the peptides
derived from bovine milk [45]. Some properties of bioactive peptides derived from bovine milk casein
are reported below.
Some authors showed that some peptides derived from αs1-casein and from β-caseins
known as casokinins (particularly fragments 177–183 and 193–202) inhibit the in vitro activity of
angiotensin-converting-enzyme (ACE) [75], thus acting as anti-hypertensive agents. A similar result
was obtained by other authors, which showed that some peptides derived fro milk whey and casein
proteins possess ACE-inhibitory activity, in particular the peptides identified were from αs1-casein
(fragments 142–147, 157–164 and 194–199) and β-caseins (fragments 108–113, 177–183 and 193–198) [76].
The in vitro enzymatic hydrolysis of β-casein produces several peptides with opioid-like activity
and characterized by a common N-terminal sequence Tyr-Gly-Gly-Phe. The presence of a Tyr residue
at the N-terminus is important for the opioid activity. The most important opioid peptides are
the β-casomorphins, which are fragments of β-caseins between the 60th and 70th residues [72].
The presence of these bioactive peptide has effect on central nervous system (analgesic and sedative
action), and on the endocrine system.
Furthermore, the bioactive peptides derived from caseins also show also immunomodulatory
activity (stimulation of the immune system) and antimicrobial activity (inhibition of pathogens).
It has been proven that the digestion of human and bovine milk caseins releases peptides
with immunostimulating activity. Parker and co-workers [77] demonstrated in particular
the immunomodulatory activity of the fragment 54–50 of human β-casein (hexapeptide
Val-Glu-Pro-Ile-Pro-Tyr).
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4. Conclusions
Donkey milk could be considered a valid replacement for human milk for clinical tolerability,
palatability, and nutritional adequacy for children affected by CMPA. It could also furnish additional
physiological functions, such as providing antibacterial substances, digestive activity molecules,
growth factors, and hormones. In children’s nutrition, the use of natural milk, rather than a formula
during the cow’s milk free diet period, should be encouraged. In this context, it is very important that
the nutraceutical role is discovered for donkey milk, because of its content of functional proteins and
peptides that have immunological-like properties and are able to stimulate the functional recovery
and development of the neonatal intestine. In particular, in the whey protein fraction, it is worth
mentioning the presence of a good amount of α-lactalbumin which, besides being implicated in
lactose synthesis, also induces apoptosis in cancer cells when complexed with oleic acid (HAMLET)
as demonstrated by in vivo and in vitro experiments. A high amount of lysozyme which shows a
bactericidal action against several pathogens and, similarly to α-lactalbumin, can form complex with
oleic acid with bactericidal action called ELOA. Donkey milk contains a discrete amount of lactoferrin
which display several positive effects on human health such as iron homeostasis, antimicrobial activity,
cellular growth differentiation, anti-inflammatory activity, protection against cancer development, and
metastasis. Furthermore, once digested in the stomach, lactoferrin is fragmented into small peptides
with a more potent action against several bacteria, viruses, fungal pathogens and protozoa, with
respect to the full-length lactoferrin from which they derive. Finally, in donkey milk whey protein
fraction, the presence of small peptides derived from β -casein, whose sequence was found to be
similar to that of peptides derived from bovine β-caseins, was demonstrated. The function of these
peptides derived from donkey milk β-casein is not well elucidated yet, but it can be supposed that
they may have roles on cardiovascular, digestive, nervous, and immune systems as described for the
bovine counterpart.
The structural similarities between human and donkey milk proteins could contribute to explain
the results of clinical studies performed by using this milk [22,26,78] indicating that donkey milk may
be a valid substitute of cow milk for feeding allergic children. Furthermore, the nutraceutical and
functional properties determined in donkey milk could be considered valid reasons for the production
of starting formulas based on donkey milk.
However, in the use of donkey milk for infant nutrition, it should also be taken into account the
low lipid content, and consequently its low energetic value, which could limit the use of this kind of
milk for feeding children affected by CMPA [79]. For this purpose, more clinical studies designed to
evaluate the nutritional efficiency of donkey milk in the first years of life should be encouraged, since
until now the case studies reported in literature are still too few.
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